BlackRock Fund Advisors’s Assembly Biosciences ASMB Stock Holding History

BlackRock Fund Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$588K	Buy	4,032 +255	+7%	+$37.9K	﹤0.01%	3251
2016 Q3	$327K	Buy	3,777 +552	+17%	+$42.6K	﹤0.01%	3312
2016 Q2	$215K	Sell	3,225 -28,560	-90%	-$1.87M	﹤0.01%	3423
2016 Q1	$1.92M	Sell	31,785 -236	-0.7%	-$15.8K	﹤0.01%	3090
2015 Q4	$2.89M	Buy	32,021 +874	+3%	+$95.2K	﹤0.01%	3053
2015 Q3	$3.57M	Sell	31,147 -352	-1%	-$61.9K	﹤0.01%	2961
2015 Q2	$7.28M	Buy	+31,499	New	+$6.08M	﹤0.01%	2689
2014 Q2	–	Sell	-1,266	Closed	-$97K	–	3857
2014 Q1	$97K	Buy	1,266 +154	+14%	+$24K	﹤0.01%	3589
2013 Q4	$255K	Buy	1,112 +46	+4%	+$8.37K	﹤0.01%	3366
2013 Q3	$185K	Buy	1,066 +84	+9%	+$12.9K	﹤0.01%	3411
2013 Q2	$141K	Buy	+982	New	+$154K	﹤0.01%	3437

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Fund Advisors's ASMB Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Assembly Biosciences (ASMB) stake by 6.8% in Q4 2016, buying an estimated $37.9K and bringing the position to 4,032 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #3251.

BlackRock Fund Advisors first reported a position in ASMB in Q2 2013 and has held it in 11 quarters since. The position peaked at $7.28M in Q2 2015. 36 funds tracked by Wall St. Rank hold ASMB as of Q4 2016.

BlackRock Fund Advisors held 4,032 shares of Assembly Biosciences worth $588K as of Q4 2016.
BlackRock Fund Advisors bought 255 Assembly Biosciences shares in Q4 2016, an estimated $37.9K.
Assembly Biosciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3251 holding.
BlackRock Fund Advisors first reported a position in Assembly Biosciences in Q2 2013 and has held it in 11 quarters since.
BlackRock Fund Advisors's Assembly Biosciences position peaked at $7.28M in Q2 2015.
36 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.